Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-29

Clinical Trial Update: Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating Hylan G-F 20 for improving exercise capacity in knee osteoarthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hylan G-F 20

Snippet

Sponsor: OhioHealth | Conditions: Knee Osteoarthritis | Phase 1 | Status: TERMINATED